GT201200336AA - PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ANTI-CONCEPTIVE KIT (DIVISIONAL APPLICATION NO. 1) - Google Patents

PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ANTI-CONCEPTIVE KIT (DIVISIONAL APPLICATION NO. 1)

Info

Publication number
GT201200336AA
GT201200336AA GT201200336AK GT201200336K GT201200336AA GT 201200336A A GT201200336A A GT 201200336AA GT 201200336A K GT201200336A K GT 201200336AK GT 201200336 K GT201200336 K GT 201200336K GT 201200336A A GT201200336A A GT 201200336AA
Authority
GT
Guatemala
Prior art keywords
conceptive
pharmaceutical composition
composition including
kit
drospirenone
Prior art date
Application number
GT201200336AK
Other languages
Spanish (es)
Inventor
Velada Jose
Drouin Dominique
Perrin Philippe
Original Assignee
Laboratorios Leon Farma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48802149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT201200336A(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Leon Farma Sa filed Critical Laboratorios Leon Farma Sa
Publication of GT201200336AA publication Critical patent/GT201200336AA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE AL CAMPO DE LAS COMPOSICIONES FARMACÉUTICAS Y MÉTODOS ANTICONCEPTIVOS. LA PRESENTE INVENCIÓN PROPORCIONA UNA COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE DROSPIRENONA CARACTERIZADA POR UNA VELOCIDAD DE DISOLUCIÓN LENTA DE LA DROSPIRENONA IN VITRO Y UN PERFIL FARMACOCINÉTICO MEJORADO. ESTÁ ASIMISMO PREVISTA LA UTILIZACIÓN DE DICHA COMPOSICIÓN EN LOS MÉTODOS ANTICONCEPTIVOS Y EN LOS KITS.THE PRESENT INVENTION CONCERNS THE FIELD OF PHARMACEUTICAL COMPOSITIONS AND ANTI-CONCEPTIVE METHODS. THE PRESENT INVENTION PROVIDES A PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE CHARACTERIZED BY A SLOW DISSOLUTION SPEED OF DROSPIRENONE IN VITRO AND AN IMPROVED PHARMACOCINETIC PROFILE. THE USE OF SUCH COMPOSITION IN ANTI-CONTRACEPTIVE METHODS AND IN KITS IS ALSO PROVIDED.

GT201200336AK 2010-06-29 2012-12-12 PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ANTI-CONCEPTIVE KIT (DIVISIONAL APPLICATION NO. 1) GT201200336AA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10305708 2010-06-29
US36839610P 2010-07-28 2010-07-28

Publications (1)

Publication Number Publication Date
GT201200336AA true GT201200336AA (en) 2017-10-23

Family

ID=48802149

Family Applications (3)

Application Number Title Priority Date Filing Date
GT201200336BL GT201200336BA (en) 2010-06-29 2012-12-12 PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ANTI-CONCEPTIVE KIT (DIVISIONAL APPLICATION NO. 2)
GT201200336A GT201200336A (en) 2010-06-29 2012-12-12 PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ANTI-CONCEPTIVE KIT
GT201200336AK GT201200336AA (en) 2010-06-29 2012-12-12 PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ANTI-CONCEPTIVE KIT (DIVISIONAL APPLICATION NO. 1)

Family Applications Before (2)

Application Number Title Priority Date Filing Date
GT201200336BL GT201200336BA (en) 2010-06-29 2012-12-12 PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ANTI-CONCEPTIVE KIT (DIVISIONAL APPLICATION NO. 2)
GT201200336A GT201200336A (en) 2010-06-29 2012-12-12 PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ANTI-CONCEPTIVE KIT

Country Status (14)

Country Link
KR (1) KR102210982B1 (en)
BR (1) BR122019008317A2 (en)
CL (1) CL2012003685A1 (en)
CO (1) CO6640328A2 (en)
DK (1) DK2588114T3 (en)
EC (3) ECSP12012359A (en)
ES (1) ES2777886T3 (en)
GT (3) GT201200336BA (en)
HR (1) HRP20200155T1 (en)
HU (1) HUE047689T2 (en)
LT (2) LT2588114T (en)
MX (3) MX339952B (en)
PT (1) PT2588114T (en)
ZA (1) ZA201209743B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009138224A1 (en) * 2008-05-14 2009-11-19 Helm Ag Pharmaceutical composition comprising drospirenone

Also Published As

Publication number Publication date
LTPA2021523I1 (en) 2021-11-10
ZA201209743B (en) 2014-03-26
ECSP15032911A (en) 2016-01-29
GT201200336BA (en) 2017-10-23
BR122019008317A2 (en) 2020-09-29
HRP20200155T1 (en) 2020-05-01
ES2777886T3 (en) 2020-08-06
MX2012014629A (en) 2013-05-06
KR102210982B1 (en) 2021-02-02
CO6640328A2 (en) 2013-03-22
ECSP15032906A (en) 2016-01-29
KR20190073598A (en) 2019-06-26
MX339952B (en) 2016-06-20
DK2588114T3 (en) 2020-02-17
MX364971B (en) 2019-05-16
GT201200336A (en) 2014-01-14
LT2588114T (en) 2020-02-25
CL2012003685A1 (en) 2013-07-05
ECSP12012359A (en) 2013-03-28
HUE047689T2 (en) 2020-05-28
MX2019004393A (en) 2019-09-09
PT2588114T (en) 2020-02-20

Similar Documents

Publication Publication Date Title
AR081670A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ANTI-ECONCEPTIVE KIT
CR20110216A (en) 1-AMINO-2-CYCLLOBUTILETILBORONIC ACID DERIVATIVES
UY32626A (en) BETA-LACTAMASA INHIBITORS
UY31561A1 (en) AZOLILMETILOXIRANOS, ITS USE AND AGENTS THAT CONTAIN THEM
CR20140216A (en) 5,7-IMIDAZO [1,2-C] SUBSTITUTED PYRIMIDINS
CO6541602A2 (en) ORAL COMPOSITIONS CONTAINING EXTRACTS OF ZIZYPHUS JOAZEIRO AND RELATED METHOD
CL2012001911A1 (en) Compounds derived from fumarate; pharmaceutical composition comprising them; and its use in the treatment of an inflammatory or neurodegenerative disease.
ECSP10010129A (en) INHIBITORS OF KINESAS SIMILAR POLO
CL2008003284A1 (en) Compounds derived from 4-benzylamino-1-carboxyacyl-pyridine, cetp inhibitors; pharmaceutical composition comprising them; pharmaceutical combination; and use in the treatment of metabolic, atherosclerosis and cardiovascular diseases, among others.
UY34112A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A NEUROLEPTIC AGENT AND A SGLT2 INHIBITOR AND USES OF THE SAME
CU20120171A7 (en) SUBSTITUTED TRIAZOLOPIRIDINS
HN2008001393A (en) DERIVATIVES OF 1,2,4,5- TETRAHIDRO -3H- BENZAZEPINAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HN2008001521A (en) DIMEROS OF ARTEMISININE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
NI200800227A (en) 1,3-DIOXANE CARBOXYL ACIDS
UY32704A (en) COMPOUNDS OF 2,3-DIHIDRO-1H-INDENO
CR10654A (en) AGENTS UNDERSTANDING COMPOUNDS MARKED WITH 18F AND RELATED METHODS
ECSP11011340A (en) NEW DERIVATIVES OF BENZOTIADIAZEPINAS, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CO6420349A2 (en) NOVEDOSO DERIVATIVES OF STEROIDAL COMPOUNDS [3,2-C] PIRAZOLES WITH GLUCOCORTICOID ACTIVITY
UY31990A (en) NEW DERIVATIVES
AR063027A1 (en) SULFONAMIDE DERIVATIVES
HN2011000404A (en) ENFUMAFUNGINA AND COMPOSITION DERIVATIVES UNDERSTANDING THE SAME
AR077429A1 (en) HYDROXIASENAPINA COMPOUNDS ITS DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE SAME
GT201200336AA (en) PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ANTI-CONCEPTIVE KIT (DIVISIONAL APPLICATION NO. 1)
DK2155886T3 (en) Cosmetic use of tyrosinase inhibitors
CR20120109A (en) NEW DIHIDRO-OXAZOLOBENZODIAZEPINONAS DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM